Human medicines European public assessment report (EPAR): Juluca, dolutegravir,rilpivirine, Date of authorisation: 16/05/2018, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 01/07/2019, Revision: 19, Status: Authorised

European Medicines Agency and Transcelerate bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 17 November 2025

Human medicines European public assessment report (EPAR): Zypadhera, olanzapine, Date of authorisation: 19/11/2008, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Tivicay, dolutegravir, Date of authorisation: 16/01/2014, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Triumeq, abacavir,dolutegravir,lamivudine, Date of authorisation: 31/08/2014, Revision: 37, Status: Authorised

Medicine shortage communications (MSC)

Bronchitol

Medicine shortage communication (MSC) : Bronchitol, 40 mg inhalation powder, hard capsules: ongoing shortage

Substance and product data management services